RAPP · Rapport Therapeutics, Inc.
$47.42
+0.06 (+0.13%)
At close · Aug 14
Market Cap
$2.28B
Shares
47.98M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-10 | — | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2026-06-10 | |
| 8-K | 2026-04-21 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-09-10 | 2025-09-09 | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-17 | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-10 | 2024-06-06 |
Showing 1–34 of 34 filings
Key facts
CIK
2012593
CUSIP
75383L102
13F (30d)
156 filings
153 filers
Visit website
Investor relations